Aytu Biopharma (AYTU) EBITDA Margin (2013 - 2026)
Aytu Biopharma (AYTU) reported EBITDA Margin of 2.14% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 42.83 percentage points from -40.69% a year earlier and up 25.85 percentage points from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) EBITDA Margin (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma posted EBITDA Margin of -7.62%, down 3.93 percentage points from FY2025.
- EBITDA Margin has a five-year change of +68.06 percentage points (FY2021 to FY2026).
- By fiscal year, EBITDA Margin came in at -3.69% in FY2025 (-11.57 pp), 7.88% in FY2024 (+15.56 pp), -7.68% in FY2023 (+95.52 pp) and -103.20% in FY2022 (-27.52 pp).
- The fiscal Q4 2026 figure ranks as the highest quarterly EBITDA Margin since fiscal Q3 2025.
- Year over year, EBITDA Margin gained in two of the last eight quarters, with an average year-over-year change of -7.80 percentage points.
- The high point for year-over-year EBITDA Margin in five years was fiscal Q3 2023 (a gain of 182.12 percentage points); the low point was fiscal Q1 2022 (a drop of 103.01 percentage points).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -23.71% (Q3 2026), -7.15% (Q2 2026) and -5.05% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | 2.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.14% |
| Mar 31, 2026 | -23.71% |
| Dec 31, 2025 | -7.15% |
| Sep 30, 2025 | -5.05% |
| Jun 30, 2025 | -40.69% |
| Mar 31, 2025 | 20.10% |
| Dec 31, 2024 | -2.48% |
| Sep 30, 2024 | 2.44% |
| Jun 30, 2024 | -4.90% |
| Mar 31, 2024 | -0.46% |
| Dec 31, 2023 | 24.27% |
| Sep 30, 2023 | 7.65% |
| Jun 30, 2023 | 7.44% |
| Mar 31, 2023 | -28.00% |
| Dec 31, 2022 | -17.74% |
| Sep 30, 2022 | 1.78% |
| Jun 30, 2022 | -53.63% |
| Mar 31, 2022 | -210.12% |
| Dec 31, 2021 | -37.27% |
| Sep 30, 2021 | -114.27% |
API Access
Aytu Biopharma EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();